Utilisation de la mitoxantrone dans les formes malignes inaugurales de sclérose en plaques. Étude observationnelle de 30 cas. Évaluations cliniques et IRM à un an

In our experience, mitoxantrone had a rapid and strong impact on the malignant forms of MS with a short disease duration. In this MS subgroup, mitoxantrone should be considered as an early treatment option.